Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen E Corey

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 22, 2013
Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseKathleen E Corey, Naga Chalasani
Clinical Liver Disease|June 13, 2019
Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver diseaseKathleen E Corey, Raj Vuppalanchi
Hepatology (Baltimore, Md.)|September 29, 2011
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?Kathleen E Corey, Naga Chalasani
Therapeutic Advances in Gastroenterology|December 25, 2010
Current status of therapy for hepatocellular carcinomaKathleen E Corey, Daniel S Pratt
Digestive Diseases and Sciences|March 5, 2016
Medical and Surgical Treatment Options for Nonalcoholic SteatohepatitisKathleen E Corey, Mary E Rinella
JAMA|November 11, 2021
Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic SteatohepatitisKathleen E Corey, Zoe Nicole Memel
Gastroenterology|December 7, 2007
Treating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelopeKathleen E Corey, Raymond T Chung
Clinics in Liver Disease|November 27, 2013
Obesity and liver disease: the epidemic of the twenty-first centuryKathleen E Corey, Lee M Kaplan
Alimentary Pharmacology & Therapeutics|April 28, 2020
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' replyJacqueline B Henson, Kathleen E Corey
Clinical Liver Disease|May 2, 2019
Interpretation of abnormal liver chemistries in the hospitalized patientJorge E Sanchez, Kathleen E Corey
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 22, 2013
Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseKathleen E Corey, Naga Chalasani
Clinical Liver Disease|June 13, 2019
Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver diseaseKathleen E Corey, Raj Vuppalanchi
Hepatology (Baltimore, Md.)|September 29, 2011
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?Kathleen E Corey, Naga Chalasani
Therapeutic Advances in Gastroenterology|December 25, 2010
Current status of therapy for hepatocellular carcinomaKathleen E Corey, Daniel S Pratt
Digestive Diseases and Sciences|March 5, 2016
Medical and Surgical Treatment Options for Nonalcoholic SteatohepatitisKathleen E Corey, Mary E Rinella
JAMA|November 11, 2021
Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic SteatohepatitisKathleen E Corey, Zoe Nicole Memel
Gastroenterology|December 7, 2007
Treating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelopeKathleen E Corey, Raymond T Chung
Clinics in Liver Disease|November 27, 2013
Obesity and liver disease: the epidemic of the twenty-first centuryKathleen E Corey, Lee M Kaplan
Alimentary Pharmacology & Therapeutics|April 28, 2020
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' replyJacqueline B Henson, Kathleen E Corey
Clinical Liver Disease|May 2, 2019
Interpretation of abnormal liver chemistries in the hospitalized patientJorge E Sanchez, Kathleen E Corey
Pageof 16